Catalyst Pharmaceutical
CPRX
CPRX
131 hedge funds and large institutions have $254M invested in Catalyst Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 49 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 130 → 131 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 49
Holders
131
Holding in Top 10
1
Calls
$819K
Puts
$239K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$5.57M | |
| 3 | +$4.04M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$3.82M |
| 5 |
Millennium Management
New York
|
+$3.08M |
Top Sellers
| 1 | -$6.74M | |
| 2 | -$2.91M | |
| 3 | -$2.86M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.74M |
| 5 |
Two Sigma Investments
New York
|
-$2.68M |